Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Healthcare ETF Vanguard
(NY:
VHT
)
281.33
+1.43 (+0.51%)
Official Closing Price
Updated: 8:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Healthcare ETF Vanguard
< Previous
1
2
Next >
Rebalanced ESG ETFs Index down 6.9% YTD
June 07, 2022
ESG funds did better than the broader market during the stock volatility surrounding the coronavirus pandemic.
Via
Talk Markets
2 ETFs to Watch for Outsized Volume on Healthcare and Mid-Cap
April 28, 2022
Both these funds experienced volume levels that were more than double their average for the most recent trading session. This could make these ETFs the ones to watch out for in the days ahead to see if...
Via
Talk Markets
5 Safe ETF Bets To Consider After A Dull Market Last Week
April 26, 2022
The healthcare sector is a good defensive investment option as several investors believe consumers will have to purchase healthcare products even during tough and uncertain times.
Via
Talk Markets
3 Vanguard ETFs to Buy Now
April 05, 2022
These are the best long-term Vanguard ETFs to invest in now. VUG, VHT, and VIOV can make great investments in April.
Via
InvestorPlace
5 ETF Areas for Investors to Consider Amid the September Slump
September 23, 2021
Wall Street is witnessing a tough time in the historically weak month of September.
Via
Talk Markets
Healthcare ETFs in Focus as Q2 Earnings Unfold
July 22, 2021
Let’s dig deeper into the earnings picture of the companies which will drive the performance of healthcare funds in the coming days.
Via
Talk Markets
Healthcare ETFs on Radar As Q1 Earnings Unfold
April 28, 2021
The healthcare sector has been benefiting from COVID-19 vaccines or treatment with many more to come.
Via
Talk Markets
Exposures
COVID-19
Why Bristol Myers Squibb Deserves a Place in Your Portfolio
April 22, 2021
This undervalued pharmaceutical is a great buy in 2021.
Via
The Motley Fool
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.